2026-10-09
From October 6 to 8, 2026, KHB and Tianlong successfully participated in WHX Johannesburg & WHX Labs Johannesburg 2026 at the Gallagher Convention Centre, marking KHB Group’s first independent exhibition presence in South Africa and an important step toward closer engagement with the African market.
At Booth H3.F20, KHB and Tianlong presented a series of integrated diagnostic solutions covering clinical chemistry, rapid testing, molecular diagnostics, and comprehensive laboratory applications. The booth welcomed a steady flow of local customers, distributors, hospital end users, laboratory professionals, and industry partners, creating valuable opportunities for direct communication and market feedback.


Unlike a routine exhibition appearance, this event served as a new starting point for KHB to connect with African customers face to face. Throughout the show, discussions focused on practical needs across the region, including new laboratory establishment, routine diagnostic testing in hospitals and laboratories, public health programs, government tender projects, pharmacy channel distribution and supply, product registration, training, and after-sales support.
The strong interest from local visitors also highlighted the compatibility of KHB Group’s integrated solution portfolio with the diverse needs of the African market. From newly upgraded clinical chemistry solutions to rapid testing products and molecular diagnostic platforms, KHB and Tianlong offer flexible product combinations that can support laboratories at different stages of development and across different application scenarios.
- For customers planning to build or upgrade laboratories, KHB Group provides scalable solutions that combine instruments, reagents, technical support, and service resources.
- For distributors and partners involved in public health programs and tender projects, KHB Group’s portfolio drew strong attention from local visitors. With complete qualifications, proven performance, and strong customer recognition, solutions such as PCR instruments and HIV colloidal gold rapid tests with CE-IVDR and WHOPQ became key discussion points at the booth.
KHB’s first independent appearance in South Africa was more than a product showcase. It was a meaningful step toward building stronger local connections, understanding real market needs, and bringing KHB Group’s diagnostic solutions closer to customers across Africa.
Moving forward, KHB and Tianlong will continue to strengthen communication with African partners, support local healthcare development with reliable diagnostic solutions, and explore more cooperation opportunities across the region.

